Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.43 |
| ▸ | DPP4 | P27487 | 1/20 | 0.43 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.43 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.40 |
| ▸ | BDKRB1 | P46663 | 1/20 | 0.39 |
| ▸ | KDM1A | O60341 | 1/20 | 0.39 |
| ▸ | CCR1 | P32246 | 1/20 | 0.37 |
| ▸ | TACR1 | P25103 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23778256 | 0.86 | CYP2D6 (0.48) | CYP2D6ALDH1A1TDP1HRH3 | |
| SCHEMBL23798595 | 0.83 | CYP2D6 (0.56) | CYP2D6ALDH1A1OPRL1KMT2AKDM1A | |
| SCHEMBL23798654 | 0.83 | OPRL1 (0.56) | CYP2D6OPRL1KMT2AKDM1ACCR1 | |
| SCHEMBL9435664 | 0.82 | OPRL1 (0.58) | CYP2D6OPRL1DPP4DPP8DPP9 | |
| SCHEMBL23798687 | 0.81 | CYP2D6 (0.48) | CYP2D6ALDH1A1KMT2ABDKRB1KDM1A | |
| SCHEMBL20066007 | 0.81 | HRH3 (0.51) | CYP2D6ALDH1A1KMT2AHRH3 | |
| SCHEMBL5469097 | 0.80 | KMT2A (0.64) | ALDH1A1OPRL1DPP4DPP8DPP9 | |
| SCHEMBL5469094 | 0.80 | KMT2A (0.64) | ALDH1A1OPRL1DPP4DPP8DPP9 | |
| SCHEMBL626449 | 0.80 | KDM1A (0.43) | ALDH1A1KMT2ABDKRB1KDM1A | |
| SCHEMBL1018956 | 0.80 | SLC6A4 (0.46) | ALDH1A1KMT2ABDKRB1KDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3526207-B1 | HETEROCYCLIC COMPOUNDS HAVING ACTIVITY AS MODULATORS OF MUSCARINIC M1 AND/OR M4 RECEPTORS IN THE TREATMENT OF CNS DISEASES AND PAINS. | HEPTARES THERAPEUTICS LTD (GB) | 2021-09-08 | — | — | EP | disclosed |